Takhzyro
Ended Awarded
- Contract number
- 36C26124N0483
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,890
Award facts
- Contract value 100% obligated
- $36,890.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Takeda Pharmaceuticals America Inc. a $36,890.40 firm fixed price delivery order for TAKHZYRO under the company's Pharmaceuticals and Drugs General Services Administration schedule contract. TAKHZYRO will be delivered to facilities in Lexington, Massachusetts by June 7, 2024 to support treatment of hereditary angioedema. No set-aside was applied given the specialized nature of the biopharmaceutical product. Takeda Pharmaceuticals America Inc. is a subsidiary of Takeda Pharmaceutical Company Limited that holds a $19 million blanket purchase agreement with the VA National Acquisition Center to streamline procurement of therapies for conditions including hereditary angioedema and hypocalcemia.
Quick answers
Who was awarded contract 36C26124N0483?
36C26124N0483 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 7, 2024.
How much is contract 36C26124N0483 worth?
The government has obligated $36,890 on 36C26124N0483.
Is contract 36C26124N0483 an order under another contract?
Yes. 36C26124N0483 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0483 competed?
The extent of competition for 36C26124N0483 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award